Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 97-108 of 10,612
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

In United States
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

In United States
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In United States
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07221877

Effect of KarXT on Urological Safety

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07610473

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States
DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Drug study icon
RecruitingNCT07300969

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States, in the United Kingdom, in Bulgaria, ...

In United States
DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Argentina, ...

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07227454

Esketamine for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Brazil, in Hungary, ...

In United States
DepressionDrugFrom 12 Years to 17 Years
Countries
United States, Brazil, Hungary, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.